Somatostatin and its analogues bind to somatostatin receptors (sst) 1 through 5 that are
overexpressed in neuroendocrine neoplasms such as gastroenteropancreatic (GEP) …

Objective Peptide receptor radionuclide therapy with radiolabeled somatostatin analogs is a
novel method of treatment in patients with metastatic neuroendocrine tumors (NETs). For …

Purpose Somatostatin and its analogues, such as octreotide and lanreotide, are used to treat
neuroendocrine malignancies. Somatostatin analogues bind to somatostatin receptors (sst …

Aim: To study the long term benefits, toxicity and survival rate in patients with neuroendocrine
tumors receiving multiple cycles of high activity In-111 Pentetreotide therapy. Moreover, …

Optimal cancer radiotherapy using Auger electron emitters requires selective localization of
radionuclides in close proximity to tumor DMA. Methods: Intracellular trafficking of 125l-Tyr1-…

Background: Somatostatin receptors are present in most human breast cancers. We performed
a pilot trial of intraoperative tumor-gamma detection using the radiolabeled somatostatin …

One of the new, promising areas of nuclear medicine involves radiolabeled low-molecular-weight
peptides for the diagnosis and management of cancer. Somatostatin analogous …

Background.Radiolabeled somatostatin analogs have gained popularity for tumor imaging
and have recently been used for the treatment of somatostatin receptor-expressing tumors. …

An instrumental neutron activation analysis (INAA) method for the determination of aluminum
(Al) in fish tissue was developed to aid in the investigation of Al-caused death in fish. Six …

Somatostatin analogs effectively control carcinoid syndrome symptoms. Somatostatin
receptor subtype 2 (sst 2) is commonly expressed on the surface of carcinoid and other well …